The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"MHC class I-like antigen recognition-like
".
FunFam 1: H-2 class I histocompatibility antigen, alpha chai...
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 48 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Peptide antigen binding GO:0042605
Interacting selectively and non-covalently with an antigen peptide.
|
126 |
P01889 (/ISS)
P01889 (/ISS)
P01891 (/ISS)
P01891 (/ISS)
P04222 (/ISS)
P04222 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
P05534 (/ISS)
(116 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
65 |
A0A0G2K1E1 (/IPI)
A0A0G2K2E1 (/IPI)
A0A0G2K4X1 (/IPI)
A0A0G2K8G8 (/IPI)
E9PSS8 (/IPI)
P01891 (/IPI)
P01891 (/IPI)
P01892 (/IPI)
P01892 (/IPI)
P01893 (/IPI)
(55 more) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
38 |
P01891 (/ISS)
P01891 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
P05534 (/ISS)
P10314 (/ISS)
P10314 (/ISS)
P10316 (/ISS)
P10316 (/ISS)
(28 more) |
Peptide antigen binding GO:0042605
Interacting selectively and non-covalently with an antigen peptide.
|
33 |
F1CN43 (/IDA)
P01892 (/IDA)
P01892 (/IDA)
P01901 (/IDA)
P01901 (/IDA)
P01902 (/IDA)
P01902 (/IDA)
P03989 (/IDA)
P03989 (/IDA)
P03989 (/IDA)
(23 more) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
30 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(20 more) |
Peptide antigen binding GO:0042605
Interacting selectively and non-covalently with an antigen peptide.
|
29 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(19 more) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
27 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(17 more) |
CD8 receptor binding GO:0042610
Interacting selectively and non-covalently with a CD8, a receptor found on the surface of thymocytes and cytotoxic and suppressor T-lymphocytes.
|
27 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(17 more) |
T cell receptor binding GO:0042608
Interacting selectively and non-covalently with a T cell receptor, the antigen-recognizing receptor on the surface of T cells.
|
26 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(16 more) |
TAP binding GO:0046977
Interacting selectively and non-covalently with TAP protein, transporter associated with antigen processing protein. TAP protein is a heterodimeric peptide transporter consisting of the subunits TAP1 and TAP2.
|
25 |
P01892 (/IDA)
P01892 (/IDA)
P04222 (/IDA)
P04222 (/IDA)
P04439 (/IDA)
P04439 (/IDA)
P05534 (/IDA)
P05534 (/IDA)
P10314 (/IDA)
P10314 (/IDA)
(15 more) |
Peptide binding GO:0042277
Interacting selectively and non-covalently with peptides, any of a group of organic compounds comprising two or more amino acids linked by peptide bonds.
|
24 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(14 more) |
TAP binding GO:0046977
Interacting selectively and non-covalently with TAP protein, transporter associated with antigen processing protein. TAP protein is a heterodimeric peptide transporter consisting of the subunits TAP1 and TAP2.
|
24 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(14 more) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
24 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(14 more) |
TAP complex binding GO:0062061
Interacting selectively and non-covalently with a TAP complex.
|
24 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(14 more) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
10 | P01889 (/IPI) P01889 (/IPI) P01892 (/IPI) P01892 (/IPI) P13747 (/IPI) P17693 (/IPI) P17693 (/IPI) Q30201 (/IPI) Q30201 (/IPI) Q30201 (/IPI) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
9 | A0A0G2K1E1 (/IPI) A0A0G2K2E1 (/IPI) A0A0G2K4X1 (/IPI) A0A0G2K8G8 (/IPI) E9PSS8 (/IPI) Q30201 (/IPI) Q30201 (/IPI) Q30201 (/IPI) Q6MGB9 (/IPI) |
RNA binding GO:0003723
Interacting selectively and non-covalently with an RNA molecule or a portion thereof.
|
6 | P01891 (/HDA) P01891 (/HDA) P01892 (/HDA) P01892 (/HDA) P10316 (/HDA) P10316 (/HDA) |
Peptide binding GO:0042277
Interacting selectively and non-covalently with peptides, any of a group of organic compounds comprising two or more amino acids linked by peptide bonds.
|
6 | A0A0G2K1E1 (/IDA) A0A0G2K2E1 (/IDA) A0A0G2K4X1 (/IDA) A0A0G2K8G8 (/IDA) E9PSS8 (/IDA) Q6MGB9 (/IDA) |
Peptide antigen binding GO:0042605
Interacting selectively and non-covalently with an antigen peptide.
|
6 | P01891 (/IMP) P01891 (/IMP) P13747 (/IMP) Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
6 | A0A0G2K1E1 (/IPI) A0A0G2K2E1 (/IPI) A0A0G2K4X1 (/IPI) A0A0G2K8G8 (/IPI) E9PSS8 (/IPI) Q6MGB9 (/IPI) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
5 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) P30511 (/IDA) P30511 (/IDA) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
4 | P01891 (/IMP) P01891 (/IMP) P01893 (/IMP) P13747 (/IMP) |
CD8 receptor binding GO:0042610
Interacting selectively and non-covalently with a CD8, a receptor found on the surface of thymocytes and cytotoxic and suppressor T-lymphocytes.
|
4 | P01892 (/IDA) P01892 (/IDA) P17693 (/IDA) P17693 (/IDA) |
Transferrin receptor binding GO:1990459
Interacting selectively and non-covalently with the transferrin receptor.
|
4 | P70387 (/IPI) Q30201 (/IPI) Q30201 (/IPI) Q30201 (/IPI) |
Co-receptor binding GO:0039706
Interacting selectively and non-covalently with a coreceptor. A coreceptor acts in cooperation with a primary receptor to transmit a signal within the cell.
|
3 | Q30201 (/IPI) Q30201 (/IPI) Q30201 (/IPI) |
T cell receptor binding GO:0042608
Interacting selectively and non-covalently with a T cell receptor, the antigen-recognizing receptor on the surface of T cells.
|
3 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Ribonuclease activity GO:0004540
Catalysis of the hydrolysis of phosphodiester bonds in chains of RNA.
|
2 | P25311 (/NAS) P25311 (/NAS) |
Protein transmembrane transporter activity GO:0008320
Enables the transfer of a protein from one side of a membrane to the other.
|
2 | P25311 (/NAS) P25311 (/NAS) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
2 | P01892 (/IC) P01892 (/IC) |
MHC class I protein binding GO:0042288
Interacting selectively and non-covalently with major histocompatibility complex class I molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation.
|
2 | P01902 (/IPI) P01902 (/IPI) |
MHC class I protein binding GO:0042288
Interacting selectively and non-covalently with major histocompatibility complex class I molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
2 | P17693 (/IPI) P17693 (/IPI) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | P17693 (/NAS) P17693 (/NAS) |
Natural killer cell lectin-like receptor binding GO:0046703
Interacting selectively and non-covalently with a lectin-like natural killer cell receptor.
|
2 | P06339 (/ISO) P06339 (/ISO) |
TAP1 binding GO:0046978
Interacting selectively and non-covalently with the TAP1 subunit of TAP (transporter associated with antigen processing) protein.
|
2 | P30511 (/IPI) P30511 (/IPI) |
TAP2 binding GO:0046979
Interacting selectively and non-covalently with the TAP2 subunit of TAP (transporter associated with antigen processing) protein.
|
2 | P30511 (/IPI) P30511 (/IPI) |
Chaperone binding GO:0051087
Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
|
2 | P30460 (/IPI) P30460 (/IPI) |
TAP complex binding GO:0062061
Interacting selectively and non-covalently with a TAP complex.
|
2 | P01892 (/IDA) P01892 (/IDA) |
14-3-3 protein binding GO:0071889
Interacting selectively and non-covalently with a 14-3-3 protein. A 14-3-3 protein is any of a large family of approximately 30kDa acidic proteins which exist primarily as homo- and heterodimers within all eukaryotic cells, and have been implicated in the modulation of distinct biological processes by binding to specific phosphorylated sites on diverse target proteins, thereby forcing conformational changes or influencing interactions between their targets and other molecules. Each 14-3-3 protein sequence can be roughly divided into three sections: a divergent amino terminus, the conserved core region and a divergent carboxy-terminus. The conserved middle core region of the 14-3-3s encodes an amphipathic groove that forms the main functional domain, a cradle for interacting with client proteins.
|
2 | P30511 (/IDA) P30511 (/IDA) |
MHC class I receptor activity GO:0032393
Combining with an MHC class I protein complex to initiate a change in cellular activity. Class I here refers to classical class I molecules.
|
1 | Q95460 (/TAS) |
Co-receptor binding GO:0039706
Interacting selectively and non-covalently with a coreceptor. A coreceptor acts in cooperation with a primary receptor to transmit a signal within the cell.
|
1 | P70387 (/ISO) |
MHC class I protein binding GO:0042288
Interacting selectively and non-covalently with major histocompatibility complex class I molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation.
|
1 | P13747 (/IDA) |
MHC class II protein binding GO:0042289
Interacting selectively and non-covalently with major histocompatibility complex class II molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation.
|
1 | U3PTD3 (/IPI) |
Natural killer cell lectin-like receptor binding GO:0046703
Interacting selectively and non-covalently with a lectin-like natural killer cell receptor.
|
1 | P13747 (/IPI) |
Transferrin receptor binding GO:1990459
Interacting selectively and non-covalently with the transferrin receptor.
|
1 | P70387 (/ISO) |
There are 211 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Antigen processing and presentation of peptide antigen via MHC class I GO:0002474
The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO:0002479
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent GO:0002480
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Regulation of immune response GO:0050776
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Interferon-gamma-mediated signaling pathway GO:0060333
A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Type I interferon signaling pathway GO:0060337
A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Positive regulation of T cell mediated cytotoxicity GO:0001916
Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.
|
34 |
A0A0G2K1E1 (/IDA)
A0A0G2K2E1 (/IDA)
A0A0G2K4X1 (/IDA)
A0A0G2K8G8 (/IDA)
E9PSS8 (/IDA)
P01892 (/IDA)
P01892 (/IDA)
P01895 (/IDA)
P01899 (/IDA)
P01899 (/IDA)
(24 more) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
26 |
P01889 (/NAS)
P01889 (/NAS)
P01893 (/NAS)
P04439 (/NAS)
P04439 (/NAS)
P13746 (/NAS)
P13746 (/NAS)
P16188 (/NAS)
P30443 (/NAS)
P30443 (/NAS)
(16 more) |
Protection from natural killer cell mediated cytotoxicity GO:0042270
The process of protecting a cell from natural killer cell mediated cytotoxicity.
|
15 |
P01889 (/IDA)
P01889 (/IDA)
P05534 (/IDA)
P05534 (/IDA)
P10314 (/IDA)
P10314 (/IDA)
P13746 (/IDA)
P13746 (/IDA)
P13747 (/IDA)
P17693 (/IDA)
(5 more) |
Antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent GO:0002485
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-dependent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following TAP-dependent transport from the cytosol. Class I here refers to classical class I molecules.
|
13 |
P01895 (/IDA)
P01899 (/IDA)
P01899 (/IDA)
P01900 (/IDA)
P01901 (/IDA)
P01901 (/IDA)
P01902 (/IDA)
P01902 (/IDA)
P03991 (/IDA)
P04223 (/IDA)
(3 more) |
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
13 |
P01895 (/IDA)
P01899 (/IDA)
P01899 (/IDA)
P01900 (/IDA)
P01901 (/IDA)
P01901 (/IDA)
P01902 (/IDA)
P01902 (/IDA)
P03991 (/IDA)
P04223 (/IDA)
(3 more) |
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
13 |
P01895 (/IMP)
P01899 (/IMP)
P01899 (/IMP)
P01900 (/IMP)
P01901 (/IMP)
P01901 (/IMP)
P01902 (/IMP)
P01902 (/IMP)
P03991 (/IMP)
P04223 (/IMP)
(3 more) |
Antigen processing and presentation of exogenous peptide antigen via MHC class I GO:0042590
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules.
|
13 |
P01892 (/IDA)
P01892 (/IDA)
P01901 (/IDA)
P01901 (/IDA)
P01902 (/IDA)
P01902 (/IDA)
P03991 (/IDA)
P04223 (/IDA)
P04439 (/IDA)
P04439 (/IDA)
(3 more) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
10 | P01901 (/IDA) P01901 (/IDA) P01902 (/IDA) P01902 (/IDA) P03991 (/IDA) P04223 (/IDA) P14428 (/IDA) Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
Antigen processing and presentation of endogenous peptide antigen via MHC class Ib GO:0002476
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
9 | P13747 (/IDA) P14431 (/IDA) P17693 (/IDA) P17693 (/IDA) P30511 (/IDA) P30511 (/IDA) Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
Neutrophil degranulation GO:0043312
The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.
|
9 | P01889 (/TAS) P01889 (/TAS) P01893 (/TAS) P10321 (/TAS) P10321 (/TAS) P30453 (/TAS) P30453 (/TAS) P30459 (/TAS) P30459 (/TAS) |
Inner ear development GO:0048839
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
|
9 | P01901 (/IDA) P01901 (/IDA) P01902 (/IDA) P01902 (/IDA) P03991 (/IDA) P04223 (/IDA) P06339 (/IDA) P06339 (/IDA) P14428 (/IDA) |
Antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent GO:0002486
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-independent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following transport from the cytosol via a TAP-independent pathway. Class I here refers to classical class I molecules.
|
8 | P01892 (/IDA) P01892 (/IDA) P03989 (/IDA) P03989 (/IDA) P03989 (/IDA) P18464 (/IDA) P18464 (/IDA) P30499 (/IDA) |
Negative regulation of natural killer cell mediated cytotoxicity GO:0045953
Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity.
|
8 | A0A0G2K1E1 (/IMP) A0A0G2K2E1 (/IMP) A0A0G2K4X1 (/IMP) A0A0G2K8G8 (/IMP) E9PSS8 (/IMP) P17693 (/IMP) P17693 (/IMP) Q6MGB9 (/IMP) |
Protein ubiquitination GO:0016567
The process in which one or more ubiquitin groups are added to a protein.
|
7 | P01892 (/TAS) P01892 (/TAS) P04439 (/TAS) P04439 (/TAS) Q9MY60 (/TAS) Q9MY60 (/TAS) Q9MY60 (/TAS) |
CD8-positive, alpha-beta T cell activation GO:0036037
The change in morphology and behavior of a CD8-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
7 | P01892 (/IDA) P01892 (/IDA) P04439 (/IDA) P04439 (/IDA) P13747 (/IDA) P30443 (/IDA) P30443 (/IDA) |
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
|
7 | P04222 (/TAS) P04222 (/TAS) P13747 (/TAS) P30504 (/TAS) P30504 (/TAS) Q95365 (/TAS) Q95365 (/TAS) |
Antigen processing and presentation of exogenous peptide antigen via MHC class Ib GO:0002477
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
6 | P13747 (/IDA) P30511 (/IDA) P30511 (/IDA) Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
T cell tolerance induction GO:0002517
A process involving any mechanism for tolerance induction in T cells.
|
6 | A0A0G2K1E1 (/IMP) A0A0G2K2E1 (/IMP) A0A0G2K4X1 (/IMP) A0A0G2K8G8 (/IMP) E9PSS8 (/IMP) Q6MGB9 (/IMP) |
Positive regulation of tolerance induction to nonself antigen GO:0002657
Any process that activates or increases the frequency, rate, or extent of tolerance induction to nonself antigen.
|
6 | A0A0G2K1E1 (/IMP) A0A0G2K2E1 (/IMP) A0A0G2K4X1 (/IMP) A0A0G2K8G8 (/IMP) E9PSS8 (/IMP) Q6MGB9 (/IMP) |
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
6 | P01895 (/IGI) P01899 (/IGI) P01899 (/IGI) P01900 (/IGI) P14426 (/IGI) P14427 (/IGI) |
Positive regulation of T cell mediated cytotoxicity GO:0001916
Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.
|
5 | P30511 (/IMP) P30511 (/IMP) Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Antigen processing and presentation of endogenous peptide antigen via MHC class Ib GO:0002476
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
5 | P06339 (/ISO) P06339 (/ISO) Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of natural killer cell cytokine production GO:0002729
Any process that activates or increases the frequency, rate, or extent of natural killer cell cytokine production.
|
5 | P13747 (/IDA) P17693 (/IDA) P17693 (/IDA) P30511 (/IDA) P30511 (/IDA) |
Positive regulation of natural killer cell cytokine production GO:0002729
Any process that activates or increases the frequency, rate, or extent of natural killer cell cytokine production.
|
5 | P06339 (/ISO) P06339 (/ISO) Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
5 | P03989 (/IMP) P03989 (/IMP) P03989 (/IMP) P30443 (/IMP) P30443 (/IMP) |
Detection of bacterium GO:0016045
The series of events in which a stimulus from a bacterium is received and converted into a molecular signal.
|
5 | P03989 (/IMP) P03989 (/IMP) P03989 (/IMP) P30443 (/IMP) P30443 (/IMP) |
Protection from natural killer cell mediated cytotoxicity GO:0042270
The process of protecting a cell from natural killer cell mediated cytotoxicity.
|
5 | P06339 (/ISO) P06339 (/ISO) Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Negative regulation of natural killer cell mediated cytotoxicity GO:0045953
Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity.
|
5 | P13747 (/IDA) P17693 (/IDA) P17693 (/IDA) P30511 (/IDA) P30511 (/IDA) |
Negative regulation of natural killer cell mediated cytotoxicity GO:0045953
Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity.
|
5 | P06339 (/ISO) P06339 (/ISO) Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
T cell mediated cytotoxicity GO:0001913
The directed killing of a target cell by a T cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
|
4 | P04439 (/IDA) P04439 (/IDA) P30443 (/IDA) P30443 (/IDA) |
Defense response GO:0006952
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
|
4 | P01897 (/TAS) P03989 (/TAS) P03989 (/TAS) P03989 (/TAS) |
Antigen processing and presentation of endogenous peptide antigen via MHC class I GO:0019885
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules.
|
4 | P01892 (/IDA) P01892 (/IDA) P30443 (/IDA) P30443 (/IDA) |
Negative regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032435
Any process that stops, prevents, or reduces the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
4 | P70387 (/IC) Q30201 (/IC) Q30201 (/IC) Q30201 (/IC) |
Iron ion homeostasis GO:0055072
Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell.
|
4 | P70387 (/IMP) Q30201 (/IMP) Q30201 (/IMP) Q30201 (/IMP) |
Negative regulation of T cell mediated cytotoxicity GO:0001915
Any process that stops, prevents, or reduces the rate of T cell mediated cytotoxicity.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Response to molecule of bacterial origin GO:0002237
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
|
3 | Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
Alpha-beta T cell activation involved in immune response GO:0002287
The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response.
|
3 | Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Peripheral B cell tolerance induction GO:0002451
Tolerance induction of mature B cells in the peripheral lymphoid tissues: the blood, lymph nodes, spleen, and mucosal-associated lymphoid tissue.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent GO:0002481
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
3 | Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
Positive regulation of tolerance induction GO:0002645
Any process that activates or increases the frequency, rate, or extent of tolerance induction.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of T cell tolerance induction GO:0002666
Any process that activates or increases the frequency, rate, or extent of T cell tolerance induction.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Negative regulation of T cell cytokine production GO:0002725
Any process that stops, prevents, or reduces the frequency, rate, or extent of T cell cytokine production.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Immune response-inhibiting cell surface receptor signaling pathway GO:0002767
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell capable of inhibiting an immune response.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Cellular iron ion homeostasis GO:0006879
Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
|
3 | Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Response to iron ion GO:0010039
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.
|
3 | Q30201 (/IMP) Q30201 (/IMP) Q30201 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | Q30201 (/ISS) Q30201 (/ISS) Q30201 (/ISS) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
3 | Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Antibacterial humoral response GO:0019731
An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster.
|
3 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) |
Antigen processing and presentation GO:0019882
The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
|
3 | E9PX63 (/IMP) O19441 (/IMP) Q66JR0 (/IMP) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Positive regulation of protein binding GO:0032092
Any process that activates or increases the frequency, rate or extent of protein binding.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Positive regulation of interferon-gamma production GO:0032729
Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
|
3 | P01892 (/IDA) P01892 (/IDA) P14431 (/IDA) |
Positive regulation of interferon-gamma production GO:0032729
Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
|
3 | Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Positive regulation of interleukin-12 production GO:0032735
Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Transferrin transport GO:0033572
The directed movement of transferrin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
3 | Q30201 (/TAS) Q30201 (/TAS) Q30201 (/TAS) |
Regulation of iron ion transport GO:0034756
Any process that modulates the frequency, rate or extent of the directed movement of iron ions (Fe) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Negative regulation of T cell proliferation GO:0042130
Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
3 | Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Positive regulation of nitric oxide biosynthetic process GO:0045429
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
|
3 | Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Positive regulation of regulatory T cell differentiation GO:0045591
Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of natural killer cell mediated cytotoxicity GO:0045954
Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.
|
3 | Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Positive regulation of receptor-mediated endocytosis GO:0048260
Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
|
3 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) |
Negative regulation of protein kinase B signaling GO:0051898
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Iron ion homeostasis GO:0055072
Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell.
|
3 | Q30201 (/IC) Q30201 (/IC) Q30201 (/IC) |
Positive regulation of macrophage cytokine production GO:0060907
Any process that increases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Protein-containing complex assembly GO:0065003
The aggregation, arrangement and bonding together of a set of macromolecules to form a protein-containing complex.
|
3 | Q30201 (/TAS) Q30201 (/TAS) Q30201 (/TAS) |
Protein homotrimerization GO:0070207
The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Negative regulation of G0 to G1 transition GO:0070317
A cell cycle process that stops, prevents, or reduces the rate or extent of the transition from the G0 quiescent state to the G1 phase.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Cellular response to iron ion GO:0071281
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Positive regulation of peptide hormone secretion GO:0090277
Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
|
3 | Q30201 (/IMP) Q30201 (/IMP) Q30201 (/IMP) |
Negative regulation of receptor binding GO:1900121
Any process that stops, prevents or reduces the frequency, rate or extent of a protein or other molecule binding to a receptor.
|
3 | Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Positive regulation of receptor binding GO:1900122
Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I GO:1904283
Any process that stops, prevents or reduces the frequency, rate or extent of antigen processing and presentation of endogenous peptide antigen via MHC class I.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Positive regulation of ferrous iron binding GO:1904434
Any process that activates or increases the frequency, rate or extent of ferrous iron binding.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Positive regulation of transferrin receptor binding GO:1904437
Any process that activates or increases the frequency, rate or extent of transferrin receptor binding.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Regulation of protein localization to cell surface GO:2000008
Any process that modulates the frequency, rate or extent of protein localization to the cell surface.
|
3 | Q30201 (/IMP) Q30201 (/IMP) Q30201 (/IMP) |
Negative regulation of ubiquitin-dependent protein catabolic process GO:2000059
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
|
3 | Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Negative regulation of signaling receptor activity GO:2000272
Any process that stops, prevents or reduces the frequency, rate or extent of a signaling receptor activity.
|
3 | Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Positive regulation of signaling receptor activity GO:2000273
Any process that activates or increases the frequency, rate or extent of signaling receptor activity.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Positive regulation of endothelial cell apoptotic process GO:2000353
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of CD8-positive, alpha-beta T cell proliferation GO:2000566
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation.
|
3 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) |
Positive regulation of cellular senescence GO:2000774
Any process that activates or increases the frequency, rate or extent of cellular senescence.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Negative regulation of CD8-positive, alpha-beta T cell activation GO:2001186
Any process that stops, prevents or reduces the frequency, rate or extent of CD8-positive, alpha-beta T cell activation.
|
3 | Q30201 (/IGI) Q30201 (/IGI) Q30201 (/IGI) |
Positive regulation of CD8-positive, alpha-beta T cell activation GO:2001187
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell activation.
|
3 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) |
Negative regulation of dendritic cell differentiation GO:2001199
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell differentiation.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Detection of chemical stimulus involved in sensory perception of bitter taste GO:0001580
The series of events required for a bitter taste stimulus to be received and converted to a molecular signal.
|
2 | P25311 (/IDA) P25311 (/IDA) |
Positive regulation of antibody-dependent cellular cytotoxicity GO:0001815
Any process that activates or increases the frequency, rate or extent of antibody-dependent cellular cytotoxicity.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Retina homeostasis GO:0001895
A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function.
|
2 | P25311 (/HEP) P25311 (/HEP) |
Negative regulation of T cell mediated cytotoxicity GO:0001915
Any process that stops, prevents, or reduces the rate of T cell mediated cytotoxicity.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Positive regulation of T cell mediated cytotoxicity GO:0001916
Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Adaptive immune response GO:0002250
An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
|
2 | P06339 (/ISO) P06339 (/ISO) |
T cell mediated cytotoxicity directed against tumor cell target GO:0002419
The directed killing of a tumor cell by a T cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
|
2 | P30443 (/IDA) P30443 (/IDA) |
Peripheral B cell tolerance induction GO:0002451
Tolerance induction of mature B cells in the peripheral lymphoid tissues: the blood, lymph nodes, spleen, and mucosal-associated lymphoid tissue.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Antigen processing and presentation of exogenous peptide antigen via MHC class Ib GO:0002477
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent GO:0002485
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-dependent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following TAP-dependent transport from the cytosol. Class I here refers to classical class I molecules.
|
2 | P01892 (/IMP) P01892 (/IMP) |
Antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent GO:0002489
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
2 | P06339 (/IDA) P06339 (/IDA) |
Natural killer cell tolerance induction GO:0002519
Tolerance induction of natural killer cells.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of tolerance induction GO:0002645
Any process that activates or increases the frequency, rate, or extent of tolerance induction.
|
2 | P17693 (/IMP) P17693 (/IMP) |
Positive regulation of T cell tolerance induction GO:0002666
Any process that activates or increases the frequency, rate, or extent of T cell tolerance induction.
|
2 | P17693 (/IMP) P17693 (/IMP) |
Regulation of T cell anergy GO:0002667
Any process that modulates the frequency, rate, or extent of T cell anergy.
|
2 | P01889 (/IMP) P01889 (/IMP) |
Regulation of natural killer cell mediated immunity GO:0002715
Any process that modulates the frequency, rate, or extent of natural killer cell mediated immunity.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of natural killer cell mediated immunity GO:0002717
Any process that activates or increases the frequency, rate, or extent of natural killer cell mediated immunity.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Negative regulation of T cell cytokine production GO:0002725
Any process that stops, prevents, or reduces the frequency, rate, or extent of T cell cytokine production.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Positive regulation of T cell cytokine production GO:0002726
Any process that activates or increases the frequency, rate, or extent of T cell cytokine production.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Negative regulation of natural killer cell cytokine production GO:0002728
Any process that stops, prevents, or reduces the frequency, rate, or extent of natural killer cell cytokine production.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Immune response-inhibiting cell surface receptor signaling pathway GO:0002767
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell capable of inhibiting an immune response.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Cellular defense response GO:0006968
A defense response that is mediated by cells.
|
2 | P17693 (/TAS) P17693 (/TAS) |
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
|
2 | P25311 (/IDA) P25311 (/IDA) |
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
|
2 | Q63678 (/ISS) Q64726 (/ISS) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
2 | Q0WXI7 (/IMP) Q4KN81 (/IMP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P25311 (/NAS) P25311 (/NAS) |
Response to bacterium GO:0009617
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium.
|
2 | Q8HWF3 (/IDA) Q9XRX0 (/IDA) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Antibacterial humoral response GO:0019731
An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Regulation of interleukin-12 production GO:0032655
Any process that modulates the frequency, rate, or extent of interleukin-12 production.
|
2 | P01889 (/IMP) P01889 (/IMP) |
Regulation of interleukin-6 production GO:0032675
Any process that modulates the frequency, rate, or extent of interleukin-6 production.
|
2 | P01889 (/IMP) P01889 (/IMP) |
Positive regulation of interleukin-12 production GO:0032735
Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Positive regulation of interleukin-13 production GO:0032736
Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of interleukin-4 production GO:0032753
Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of TRAIL production GO:0032759
Any process that activates or increases the frequency, rate, or extent of TRAIL production.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of tumor necrosis factor production GO:0032760
Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of natural killer cell proliferation GO:0032819
Any process that activates or increases the frequency, rate or extent of natural killer cell proliferation.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Multicellular organism growth GO:0035264
The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
|
2 | Q0WXI7 (/IMP) Q4KN81 (/IMP) |
CD8-positive, alpha-beta T cell activation GO:0036037
The change in morphology and behavior of a CD8-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Negative regulation of T cell proliferation GO:0042130
Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Negative regulation of natural killer cell degranulation GO:0043322
Any process that stops, prevents, or reduces the rate of natural killer cell degranulation.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Positive regulation of natural killer cell degranulation GO:0043323
Any process that activates or increases the frequency, rate or extent of natural killer cell degranulation.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Positive regulation of regulatory T cell differentiation GO:0045591
Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.
|
2 | P17693 (/IMP) P17693 (/IMP) |
Positive regulation of natural killer cell mediated cytotoxicity GO:0045954
Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Regulation of defense response to virus by virus GO:0050690
Any viral process that modulates the frequency, rate, or extent of the antiviral response of the host cell or organism.
|
2 | P01892 (/TAS) P01892 (/TAS) |
Negative regulation of immune response GO:0050777
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
2 | P17693 (/IC) P17693 (/IC) |
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
|
2 | P06339 (/ISO) P06339 (/ISO) |
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Positive regulation of immunoglobulin secretion GO:0051024
Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Protein heterotetramerization GO:0051290
The formation of a protein heterotetramer, a macromolecular structure consisting of four noncovalently associated subunits, of which not all are identical.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Negative regulation of protein kinase B signaling GO:0051898
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Transmembrane transport GO:0055085
The process in which a solute is transported across a lipid bilayer, from one side of a membrane to the other.
|
2 | P25311 (/TAS) P25311 (/TAS) |
Positive regulation of macrophage cytokine production GO:0060907
Any process that increases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Protein homotrimerization GO:0070207
The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Negative regulation of G0 to G1 transition GO:0070317
A cell cycle process that stops, prevents, or reduces the rate or extent of the transition from the G0 quiescent state to the G1 phase.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Cellular response to interferon-gamma GO:0071346
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.
|
2 | P14429 (/IDA) P14431 (/IDA) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Positive regulation of endothelial cell apoptotic process GO:2000353
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Positive regulation of CD8-positive, alpha-beta T cell proliferation GO:2000566
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of memory T cell activation GO:2000568
Any process that activates or increases the frequency, rate or extent of memory T cell activation.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Positive regulation of cellular senescence GO:2000774
Any process that activates or increases the frequency, rate or extent of cellular senescence.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Positive regulation of CD8-positive, alpha-beta T cell activation GO:2001187
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell activation.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Regulation of dendritic cell differentiation GO:2001198
Any process that modulates the frequency, rate or extent of dendritic cell differentiation.
|
2 | P01889 (/IMP) P01889 (/IMP) |
Negative regulation of dendritic cell differentiation GO:2001199
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell differentiation.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Detection of chemical stimulus involved in sensory perception of bitter taste GO:0001580
The series of events required for a bitter taste stimulus to be received and converted to a molecular signal.
|
1 | Q64726 (/ISO) |
Positive regulation of antibody-dependent cellular cytotoxicity GO:0001815
Any process that activates or increases the frequency, rate or extent of antibody-dependent cellular cytotoxicity.
|
1 | P13747 (/IDA) |
Adaptive immune response GO:0002250
An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
|
1 | P13747 (/IDA) |
Cytokine production involved in immune response GO:0002367
The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus contributing to an immune response, resulting in an increase in its intracellular or extracellular levels.
|
1 | Q8HWB0 (/IMP) |
Natural killer cell tolerance induction GO:0002519
Tolerance induction of natural killer cells.
|
1 | P13747 (/IDA) |
Regulation of natural killer cell mediated immunity GO:0002715
Any process that modulates the frequency, rate, or extent of natural killer cell mediated immunity.
|
1 | P13747 (/IDA) |
Positive regulation of natural killer cell mediated immunity GO:0002717
Any process that activates or increases the frequency, rate, or extent of natural killer cell mediated immunity.
|
1 | P13747 (/IDA) |
Negative regulation of T cell cytokine production GO:0002725
Any process that stops, prevents, or reduces the frequency, rate, or extent of T cell cytokine production.
|
1 | P70387 (/ISO) |
Cellular iron ion homeostasis GO:0006879
Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
|
1 | P70387 (/ISO) |
Cellular iron ion homeostasis GO:0006879
Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
|
1 | O35799 (/TAS) |
Acute-phase response GO:0006953
An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.
|
1 | O35799 (/IEP) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
1 | Q95460 (/TAS) |
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
|
1 | Q64726 (/ISO) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
1 | O35799 (/IEP) |
Embryo implantation GO:0007566
Attachment of the blastocyst to the uterine lining.
|
1 | P14429 (/IDA) |
Response to iron ion GO:0010039
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.
|
1 | P70387 (/ISO) |
Cellular response to iron ion starvation GO:0010106
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of iron ions.
|
1 | O35799 (/IEP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | P70387 (/IMP) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
1 | P70387 (/ISO) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P70387 (/ISO) |
Positive regulation of protein binding GO:0032092
Any process that activates or increases the frequency, rate or extent of protein binding.
|
1 | P70387 (/ISO) |
Interleukin-1 beta production GO:0032611
The appearance of interleukin-1 beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
1 | Q8HWB0 (/IMP) |
Interleukin-17 production GO:0032620
The appearance of any member of the interleukin-17 family of cytokines due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
1 | Q8HWB0 (/IMP) |
Positive regulation of interleukin-13 production GO:0032736
Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.
|
1 | P13747 (/IDA) |
Positive regulation of interleukin-4 production GO:0032753
Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.
|
1 | P13747 (/IDA) |
Positive regulation of TRAIL production GO:0032759
Any process that activates or increases the frequency, rate, or extent of TRAIL production.
|
1 | P13747 (/IDA) |
Positive regulation of tumor necrosis factor production GO:0032760
Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.
|
1 | P13747 (/IDA) |
Positive regulation of natural killer cell proliferation GO:0032819
Any process that activates or increases the frequency, rate or extent of natural killer cell proliferation.
|
1 | P13747 (/IDA) |
Regulation of iron ion transport GO:0034756
Any process that modulates the frequency, rate or extent of the directed movement of iron ions (Fe) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
1 | P70387 (/ISO) |
Regulation of multicellular organism growth GO:0040014
Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.
|
1 | Q64726 (/NAS) |
Hormone biosynthetic process GO:0042446
The chemical reactions and pathways resulting in the formation of any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone.
|
1 | P70387 (/IMP) |
Positive regulation of natural killer cell mediated cytotoxicity GO:0045954
Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.
|
1 | P13747 (/IDA) |
Positive regulation of receptor-mediated endocytosis GO:0048260
Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport.
|
1 | P70387 (/ISO) |
Defense response to Gram-negative bacterium GO:0050829
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
|
1 | Q8HWB0 (/IMP) |
Positive regulation of immunoglobulin secretion GO:0051024
Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell.
|
1 | P13747 (/IDA) |
Defense response to virus GO:0051607
Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
|
1 | P14431 (/IDA) |
Iron ion homeostasis GO:0055072
Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell.
|
1 | O35799 (/IEP) |
Iron ion homeostasis GO:0055072
Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell.
|
1 | P70387 (/ISO) |
Multicellular organismal iron ion homeostasis GO:0060586
Any process involved in the maintenance of the distribution of iron stores within tissues and organs of a multicellular organism.
|
1 | P70387 (/IMP) |
Cellular response to iron ion GO:0071281
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.
|
1 | P70387 (/ISO) |
Positive regulation of peptide hormone secretion GO:0090277
Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
|
1 | P70387 (/ISO) |
Liver regeneration GO:0097421
The regrowth of lost or destroyed liver.
|
1 | O35799 (/IEP) |
Negative regulation of receptor binding GO:1900121
Any process that stops, prevents or reduces the frequency, rate or extent of a protein or other molecule binding to a receptor.
|
1 | P70387 (/ISO) |
Positive regulation of receptor binding GO:1900122
Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor.
|
1 | P70387 (/ISO) |
Negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I GO:1904283
Any process that stops, prevents or reduces the frequency, rate or extent of antigen processing and presentation of endogenous peptide antigen via MHC class I.
|
1 | P70387 (/ISO) |
Positive regulation of ferrous iron binding GO:1904434
Any process that activates or increases the frequency, rate or extent of ferrous iron binding.
|
1 | P70387 (/ISO) |
Positive regulation of transferrin receptor binding GO:1904437
Any process that activates or increases the frequency, rate or extent of transferrin receptor binding.
|
1 | P70387 (/ISO) |
Response to iron ion starvation GO:1990641
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of iron ion.
|
1 | O35799 (/IEP) |
Regulation of protein localization to cell surface GO:2000008
Any process that modulates the frequency, rate or extent of protein localization to the cell surface.
|
1 | P70387 (/ISO) |
Negative regulation of ubiquitin-dependent protein catabolic process GO:2000059
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
|
1 | P70387 (/IC) |
Negative regulation of ubiquitin-dependent protein catabolic process GO:2000059
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
|
1 | P70387 (/ISO) |
Negative regulation of signaling receptor activity GO:2000272
Any process that stops, prevents or reduces the frequency, rate or extent of a signaling receptor activity.
|
1 | P70387 (/ISO) |
Positive regulation of signaling receptor activity GO:2000273
Any process that activates or increases the frequency, rate or extent of signaling receptor activity.
|
1 | P70387 (/ISO) |
Negative regulation of CD8-positive, alpha-beta T cell activation GO:2001186
Any process that stops, prevents or reduces the frequency, rate or extent of CD8-positive, alpha-beta T cell activation.
|
1 | P70387 (/ISO) |
There are 73 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Phagocytic vesicle membrane GO:0030670
The lipid bilayer surrounding a phagocytic vesicle.
|
163 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P01895 (/TAS)
P01897 (/TAS)
P01898 (/TAS)
(153 more) |
Integral component of lumenal side of endoplasmic reticulum membrane GO:0071556
The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the lumenal side of the membrane.
|
163 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P01895 (/TAS)
P01897 (/TAS)
P01898 (/TAS)
(153 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
145 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(135 more) |
Golgi membrane GO:0000139
The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
ER to Golgi transport vesicle membrane GO:0012507
The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Early endosome membrane GO:0031901
The lipid bilayer surrounding an early endosome.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Recycling endosome membrane GO:0055038
The lipid bilayer surrounding a recycling endosome.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
128 |
P01891 (/ISS)
P01891 (/ISS)
P03989 (/ISS)
P03989 (/ISS)
P03989 (/ISS)
P04222 (/ISS)
P04222 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
(118 more) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
128 |
P01891 (/ISS)
P01891 (/ISS)
P03989 (/ISS)
P03989 (/ISS)
P03989 (/ISS)
P04222 (/ISS)
P04222 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
(118 more) |
MHC class I protein complex GO:0042612
A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.
|
128 |
P01889 (/ISS)
P01889 (/ISS)
P01891 (/ISS)
P01891 (/ISS)
P04222 (/ISS)
P04222 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
P05534 (/ISS)
(118 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
122 |
P01889 (/ISS)
P01889 (/ISS)
P01891 (/ISS)
P01891 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
P05534 (/ISS)
P10314 (/ISS)
P10314 (/ISS)
(112 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
30 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(20 more) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
26 |
P01889 (/NAS)
P01889 (/NAS)
P01893 (/NAS)
P04439 (/NAS)
P04439 (/NAS)
P13746 (/NAS)
P13746 (/NAS)
P16188 (/NAS)
P30443 (/NAS)
P30443 (/NAS)
(16 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
26 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(16 more) |
MHC class I protein complex GO:0042612
A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.
|
26 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(16 more) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
25 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(15 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
25 |
B2RWS1 (/IDA)
F1CN43 (/IDA)
P01892 (/IDA)
P01892 (/IDA)
P03989 (/IDA)
P03989 (/IDA)
P03989 (/IDA)
P04222 (/IDA)
P04222 (/IDA)
P10321 (/IDA)
(15 more) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
24 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(14 more) |
Golgi medial cisterna GO:0005797
The middle Golgi cisterna (or cisternae).
|
24 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(14 more) |
MHC class I peptide loading complex GO:0042824
A large, multisubunit complex which consists of the MHC class I-beta 2 microglobulin dimer, the transporter associated with antigen presentation (TAP), tapasin (an MHC-encoded membrane protein), the chaperone calreticulin and the thiol oxidoreductase ERp57. Functions in the assembly of peptides with newly synthesized MHC class I molecules.
|
24 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(14 more) |
Endoplasmic reticulum exit site GO:0070971
An endoplasmic reticulum part at which COPII-coated vesicles are produced.
|
24 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(14 more) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
21 |
P01889 (/HDA)
P01889 (/HDA)
P03989 (/HDA)
P03989 (/HDA)
P03989 (/HDA)
P05534 (/HDA)
P05534 (/HDA)
P10316 (/HDA)
P10316 (/HDA)
P10321 (/HDA)
(11 more) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
20 |
P01895 (/IDA)
P01899 (/IDA)
P01899 (/IDA)
P01900 (/IDA)
P01901 (/IDA)
P01901 (/IDA)
P01902 (/IDA)
P01902 (/IDA)
P03991 (/IDA)
P04223 (/IDA)
(10 more) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
17 |
O19633 (/HDA)
P01889 (/HDA)
P01889 (/HDA)
P04439 (/HDA)
P04439 (/HDA)
P17693 (/HDA)
P17693 (/HDA)
P30443 (/HDA)
P30443 (/HDA)
P30460 (/HDA)
(7 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
14 |
P01892 (/IDA)
P01892 (/IDA)
P01895 (/IDA)
P01899 (/IDA)
P01899 (/IDA)
P01900 (/IDA)
P13747 (/IDA)
P14426 (/IDA)
P14427 (/IDA)
P17693 (/IDA)
(4 more) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
11 |
P01889 (/IDA)
P01889 (/IDA)
P01892 (/IDA)
P01892 (/IDA)
P30464 (/IDA)
P30464 (/IDA)
P30511 (/IDA)
P30511 (/IDA)
Q29963 (/IDA)
Q29963 (/IDA)
(1 more) |
MHC class I protein complex GO:0042612
A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.
|
9 | P01892 (/IDA) P01892 (/IDA) P03989 (/IDA) P03989 (/IDA) P03989 (/IDA) P13747 (/IDA) P18464 (/IDA) P18464 (/IDA) P30499 (/IDA) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
8 | P01889 (/IDA) P01889 (/IDA) P01892 (/IDA) P01892 (/IDA) P30464 (/IDA) P30464 (/IDA) Q29963 (/IDA) Q29963 (/IDA) |
Secretory granule membrane GO:0030667
The lipid bilayer surrounding a secretory granule.
|
8 | P01889 (/TAS) P01889 (/TAS) P10321 (/TAS) P10321 (/TAS) P30453 (/TAS) P30453 (/TAS) P30459 (/TAS) P30459 (/TAS) |
Endoplasmic reticulum membrane GO:0005789
The lipid bilayer surrounding the endoplasmic reticulum.
|
7 | P01892 (/TAS) P01892 (/TAS) P04439 (/TAS) P04439 (/TAS) Q9MY60 (/TAS) Q9MY60 (/TAS) Q9MY60 (/TAS) |
MHC class Ib protein complex GO:0032398
A transmembrane protein complex composed of a MHC class Ib alpha chain and, in most cases, an invariant beta2-microglobin chain, and with or without a bound peptide or lipid antigen. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.
|
7 | P13747 (/IDA) P14431 (/IDA) P30511 (/IDA) P30511 (/IDA) Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
6 | P01898 (/IDA) P25311 (/IDA) P25311 (/IDA) Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Early endosome GO:0005769
A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
|
5 | P17693 (/IDA) P17693 (/IDA) Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Early endosome GO:0005769
A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
|
4 | P70387 (/ISO) Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Apical part of cell GO:0045177
The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.
|
4 | O35799 (/IDA) Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
HFE-transferrin receptor complex GO:1990712
A protein complex containing at least HFE and a transferrin receptor (either TFR1/TFRC or TFR2), proposed to play a role in the sensing of transferrin-bound Fe (Fe2-Tf) on the plasma membrane to regulate hepcidin transcription.
|
4 | P70387 (/IDA) Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
3 | Q30201 (/TAS) Q30201 (/TAS) Q30201 (/TAS) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
3 | P03989 (/TAS) P03989 (/TAS) P03989 (/TAS) |
Cytoplasmic vesicle GO:0031410
A vesicle found in the cytoplasm of a cell.
|
3 | Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Cis-Golgi network membrane GO:0033106
The lipid bilayer surrounding any of the compartments that make up the cis-Golgi network.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Basal part of cell GO:0045178
The region of a cell situated near the base. For example, in a polarized epithelial cell, the basal surface rests on the basal lamina that separates the epithelium from other tissue.
|
3 | Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
3 | Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
|
3 | Q30201 (/IDA) Q30201 (/IDA) Q30201 (/IDA) |
Golgi membrane GO:0000139
The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | P25311 (/HDA) P25311 (/HDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | P25311 (/NAS) P25311 (/NAS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | P25311 (/TAS) P25311 (/TAS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P25311 (/HDA) P25311 (/HDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P70387 (/ISO) Q64726 (/ISO) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
2 | P25311 (/HDA) P25311 (/HDA) |
Lysosomal membrane GO:0005765
The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Golgi medial cisterna GO:0005797
The middle Golgi cisterna (or cisternae).
|
2 | P01892 (/IDA) P01892 (/IDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
2 | Q29718 (/HDA) Q29718 (/HDA) |
Early endosome membrane GO:0031901
The lipid bilayer surrounding an early endosome.
|
2 | P30511 (/IDA) P30511 (/IDA) |
MHC class Ib protein complex GO:0032398
A transmembrane protein complex composed of a MHC class Ib alpha chain and, in most cases, an invariant beta2-microglobin chain, and with or without a bound peptide or lipid antigen. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Cis-Golgi network membrane GO:0033106
The lipid bilayer surrounding any of the compartments that make up the cis-Golgi network.
|
2 | P17693 (/IDA) P17693 (/IDA) |
MHC class I peptide loading complex GO:0042824
A large, multisubunit complex which consists of the MHC class I-beta 2 microglobulin dimer, the transporter associated with antigen presentation (TAP), tapasin (an MHC-encoded membrane protein), the chaperone calreticulin and the thiol oxidoreductase ERp57. Functions in the assembly of peptides with newly synthesized MHC class I molecules.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
2 | P25311 (/HDA) P25311 (/HDA) |
Endoplasmic reticulum exit site GO:0070971
An endoplasmic reticulum part at which COPII-coated vesicles are produced.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | Q63678 (/TAS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | Q95476 (/IDA) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
1 | P70387 (/ISO) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
1 | P01893 (/IMP) |
Cytoplasmic vesicle GO:0031410
A vesicle found in the cytoplasm of a cell.
|
1 | P70387 (/ISO) |
Azurophil granule membrane GO:0035577
The lipid bilayer surrounding an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.
|
1 | P01893 (/TAS) |
MHC protein complex GO:0042611
A transmembrane protein complex composed of an MHC alpha chain and, in most cases, either an MHC class II beta chain or an invariant beta2-microglobin chain, and with or without a bound peptide, lipid, or polysaccharide antigen.
|
1 | U3PTD3 (/IDA) |
Apical part of cell GO:0045177
The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.
|
1 | P70387 (/ISO) |
Basal part of cell GO:0045178
The region of a cell situated near the base. For example, in a polarized epithelial cell, the basal surface rests on the basal lamina that separates the epithelium from other tissue.
|
1 | P70387 (/ISO) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
1 | P70387 (/ISO) |
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
|
1 | P70387 (/ISO) |
Terminal web GO:1990357
An actin-rich cytoskeletal network located beneath the microvilli of the apical plasma membrane of polarized epithelial cells. In addition to actin filaments, the terminal web may contain actin-binding proteins, myosin motor proteins, and intermediate filaments. The terminal web can function as a contractile structure that influences the spatial distribution of microvilli as well as the development and morphogenesis of tissues containing polarized epithelial cells.
|
1 | O35799 (/IDA) |
Terminal web GO:1990357
An actin-rich cytoskeletal network located beneath the microvilli of the apical plasma membrane of polarized epithelial cells. In addition to actin filaments, the terminal web may contain actin-binding proteins, myosin motor proteins, and intermediate filaments. The terminal web can function as a contractile structure that influences the spatial distribution of microvilli as well as the development and morphogenesis of tissues containing polarized epithelial cells.
|
1 | P70387 (/ISO) |
HFE-transferrin receptor complex GO:1990712
A protein complex containing at least HFE and a transferrin receptor (either TFR1/TFRC or TFR2), proposed to play a role in the sensing of transferrin-bound Fe (Fe2-Tf) on the plasma membrane to regulate hepcidin transcription.
|
1 | P70387 (/ISO) |